Photo from Paul Nguyen/X
Sep 18, 2024, 11:47
Paul Nguyen: NRG GU-009/PREDICT-RT Intensification Arms completed accrual
Paul Nguyen shared a post on X:
”NRG GU-009/PREDICT-RT Intensification Arms completed accrual yesterday, 2 years ahead of schedule! Thank you NRG Oncology GU investigators and patients and let’s keep up the great momentum to accrue the De-Intensification Arms (24 vs 12 months ADT) over the next year!”
Source: Paul Nguyen/X
Paul Nguyen is a Medical Advisor at Nanocan Therapeutics Corporation and Boston Scientific. He has been with Dana-Farber Cancer Institute for over 19 years, serving as Director of Genitourinary Radiation Oncology, Professor, and Vice-Chair of Clinical Research. He is also a Professor of Radiation Oncology at Harvard Medical School.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 25, 2025, 09:24
Apr 25, 2025, 09:19
Apr 25, 2025, 09:03
Apr 25, 2025, 08:56
Apr 25, 2025, 08:46
Apr 25, 2025, 08:32